On November 7, 2025, a study revealed a discrepancy between two prevalent tests for kidney function could suggest a heightened likelihood of kidney failure, heart issues, and mortality. The research indicated that assessing both biomarkers could uncover a larger number of individuals with impaired kidney function, potentially leading to early detection and intervention to prevent adverse health outcomes.